The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
CHARACTERISTICS OF SIROLIMUS-ASSOCIATED INTERSTITIAL PNEUMONITIS IN RENAL TRANSPLANT PATIENTS
Abstract
BACKGROUND: Sirolimus, a promising new immunosuppressive drug for organ transplantation, is currently associated with side effects, such as thrombocytopenia and hyperlipidemia. METHODS: Eight renal transplant recipients, who developed unexplained interstitial pneumonitis during sirolimus therapy, were extensively re-screened for all causes of pneumonitis. RESULTS: Interstitial pneumonitis was constantly characterized by bilateral interstitial infiltrates on chest x-rays and lung computed tomography scans, with marked general symptoms in all patients but one. Bronchoalveolar lavage (BAL) disclosed lymphocytic alveolitis (mainly of the CD4 type) in seven patients and alveolar hemorrhage in one. Transbronchial lung biopsies, performed in two patients, showed bronchiolitis obliterans with organizing pneumonia combined with lymphocytic interstitial pneumonitis. Pulmonary infections were ruled out by specific stainings and cultures of BAL, bronchial aspirates, and blood cultures. After the elimination of all possible causes, sirolimus-induced pneumonitis was considered probable. Discontinuation of sirolimus in seven cases and dose reduction in the remaining case dramatically improved clinical and radiological status within a few weeks and led to complete resolution within 3 months. CONCLUSIONS: Sirolimus is very probably responsible for interstitial pneumonitis on the following grounds: (a) occurrence of pneumonitis during sirolimus therapy; (b) absence of any other causes; and (c) resolution within 3 months of sirolimus discontinuation or dose reduction. Sirolimus should now be added to the list of possible causes of pulmonary complications after renal transplantation. Discontinuation or dose reduction of sirolimus led to complete and lasting resolution of symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Groth, C. G., Bäckman, L., Morales, J.-M., Calne, R., Kreis, H., Lang, P., Touraine, J.-L., Claesson, K., Campistol, J. M., Durand, D., et al. (1999) · Transplantation · doi:10.1097/00007890-199904150-00017 · Cited by 878
Self-citationIMMUNOPHARMACOLOGY OF RAPAMYCIN
Abraham, R. T., & Wiederrecht, G. J. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.483 · Cited by 653
Kreis, H., Cisterne, J.-M., Land, W., Wramner, L., Squifflet, J.-P., Abramowicz, D., Campistol, J. M., Morales, J.-M., Grinyo, J.-M., Mourad, G., et al. (2000) · Transplantation · doi:10.1097/00007890-200004150-00009 · Cited by 536
Self-citationImmunosuppressive strategies in transplantation
Denton, M. D., Magee, C. C., & Sayegh, M. H. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07493-5 · Cited by 449
Rapamycins: Antifungal, antitumor, antiproliferative, and immunosuppressive macrolides
Morris, R. E. (1992) · Transplantation Reviews · doi:10.1016/s0955-470x(10)80014-x · Cited by 253
Interstitial Pneumonitis Associated with Sirolimus Therapy in Renal-Transplant Recipients
Morélon, E., Stern, M., & Kreis, H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430317 · Cited by 150
Self-citationDrugs that may injure the respiratory system
Foucher, P., Biour, M., Blayac, J., Godard, P., Sgro, C., Kuhn, M. U., Vergnon, J., VERVLOET, D., Pfitzenmeyer, P., Ollagnier, M., et al. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10020265 · Cited by 105
Massy, Z. A., Bandt, J. P. D., Morélon, E., Thévenin, M., Lacour, B., & Kreis, H. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.6.928 · Cited by 22
Self-citation
Cited by
Dean, P. G., Lund, W. J., Larson, T. S., Prieto, M., Nyberg, S. L., Ishitani, M. B., Kremers, W. K., & Stegall, M. D. (2004) · Transplantation · doi:10.1097/01.tp.0000123082.31092.53 · Cited by 332
Yee, K. W. L., Zeng, Z., Konopleva, M., Verstovsek, S., Ravandi, F., Ferrajoli, A., Thomas, D., Wierda, W., Apostolidou, E., Albitar, M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0764 · Cited by 285
Roles of mTOR complexes in the kidney: implications for renal disease and transplantation
Fantus, D., Rogers, N. M., Grahammer, F., Huber, T. B., & Thomson, A. W. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.108 · Cited by 208
Adverse events associated with mTOR inhibitors
Pallet, N., & Legendre, C. (2013) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.752814 · Cited by 198
Metadata
- Authors
- Morelon, E., Stern, M., Israel-Biet, D., Correas, J.-M., Danel, C., Mamzer-Bruneel, M.-F., Peraldi, M.-N., & Kreis, H.
- Venue
- Transplantation
- Published
- 2001-09
- Volume
- 72
- Issue
- 5
- Pages
- 787-790
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2006630082
- Cited by
- 274
- References
- 8
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CHARACTERISTICS OF SIROLIMUS-ASSOCIATED INTERSTITIAL PNEUMONITIS IN RENAL TRANSPLANT PATIENTS. https://app.cochat.ai/papers/10.1097/00007890-200109150-00008
- The paper
- Morelon, E., Stern, M., Israel-Biet, D., Correas, J.-M., Danel, C., Mamzer-Bruneel, M.-F., Peraldi, M.-N., & Kreis, H. (2001). CHARACTERISTICS OF SIROLIMUS-ASSOCIATED INTERSTITIAL PNEUMONITIS IN RENAL TRANSPLANT PATIENTS. Transplantation. https://doi.org/10.1097/00007890-200109150-00008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.